ERBB2 and breast cancer: In Ki67-high breast cancers, high TILs were associated with favorable DFS, irrespective of subtype, but increasing TIL levels correlated with worse DFS in the Ki67-low group (defined as ≤ 25%) with the HR+/HER2- subtype.